Chava; Satyanarayana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chava; Satyanarayana.The latest application filed is for "process for the preparation of ivacaftor and its itermediates".

Company Profile

11.41.40

Chava; Satyanarayana - Hyderabad IN
Chava; Satyanarayana - Banjara Hills IN
Chava; Satyanarayana - Jubilee Hills IN
Chava; Satyanarayana - Secunderabad IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof Grant 11,427,570 - Chava , et al. August 30, 2	2022-08-30
Process for the preparation of ivacaftor and its intermediates Grant 11,414,386 - Thatipally , et al. August 16, 2	2022-08-16
Process for the preparation of Pazopanib or a pharmaceutically acceptable salt thereof Grant 11,299,477 - Chava , et al. April 12, 2	2022-04-12
Process for the preparation and particle size reduction of pirfenidone Grant 11,066,368 - Bollu , et al. July 20, 2	2021-07-20
Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof Grant 11,040,961 - Chivukula , et al. June 22, 2	2021-06-22
Process For The Preparation Of Ivacaftor And Its Itermediates App 20200407323 - Thatipally; Suresh ; et al.	2020-12-31
Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof Grant 10,836,753 - Chivukula , et al. November 17, 2	2020-11-17
Process for the preparation of ivacaftor Grant 10,815,202 - Thatipally , et al. October 27, 2	2020-10-27
Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof Grant 10,800,809 - Dehury , et al. October 13, 2	2020-10-13
Process For The Preparation Of Pazopanib Or A Pharmaceutically Acceptable Salt Thereof App 20200262821 - CHAVA; Satyanarayana ; et al.	2020-08-20
Process For The Preparation Of Pazopanib Or A Pharmaceutically Acceptable Salt Thereof App 20200262820 - CHAVA; Satyanarayana ; et al.	2020-08-20
Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof Grant 10,738,038 - Chivukula , et al. A	2020-08-11
Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof Grant 10,730,859 - Chava , et al.	2020-08-04
Novel Polymorphs Of Dolutegravir And Salts Thereof App 20200181169 - THAIMATTAM; Ram ; et al.	2020-06-11
Process for the preparation of macitentan Grant 10,669,264 - Jamjanam , et al.	2020-06-02
Novel Polymorphs Of Dolutegravir And Salts Thereof App 20200157118 - THAIMATTAM; Ram ; et al.	2020-05-21
Polymorphs of dolutegravir and salts thereof Grant 10,654,872 - Thaimattam , et al.	2020-05-19
Polymorphs of dolutegravir and salts thereof Grant 10,647,729 - Thaimattam , et al.	2020-05-12
Process for the preparation of enzalutamide Grant 10,626,091 - Chivukula , et al.	2020-04-21
Polymorphs of dolutegravir and salts thereof Grant 10,597,404 - Thaimattam , et al.	2020-03-24
Processes for the preparation of ivacaftor Grant 10,501,419 - Thatipally , et al. Dec	2019-12-10
Co-crystals Of Sglt2 Inhibitors, Process For Their Preparation And Pharmaceutical Compositions Thereof App 20190359605 - Chivukula; Kameswar Rao ; et al.	2019-11-28
Co-crystals Of Sglt2 Inhibitors, Process For Their Preparation And Pharmaceutical Compositions Thereof App 20190352290 - CHIVUKULA; Kameswar Rao ; et al.	2019-11-21
Co-crystals Of Sglt2 Inhibitors, Process For Their Preparation And Pharmaceutical Compositions Thereof App 20190352289 - Chivukula; Kameswar Rao ; et al.	2019-11-21
Process For The Preparation Of Ivacaftor App 20190345111 - THATIPALLY; SURESH ; et al.	2019-11-14
Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof Grant 10,428,053 - Chivukula , et al. October 1, 2	2019-10-01
Processes For The Preparation Of Carfilzomib Or Pharmaceutically Acceptable Salts Thereof App 20190284231 - Dehury; Sanjay Kumar ; et al.	2019-09-19
Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof Grant 10,364,269 - Dehury , et al.	2019-07-30
Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof Grant 10,301,321 - Chava , et al.	2019-05-28
Process For The Preparation Of Enzalutamide App 20190127332 - Chivukula; Kameswar Rao ; et al.	2019-05-02
An Improved Processes For The Preparation Of Carfilzomib Or Pharmaceutically Acceptable Salts Thereof App 20190085026 - Dehury; Sanjay Kumar ; et al.	2019-03-21
Novel Polymorphs Of Dolutegravir And Salts Thereof App 20190023718 - THAIMATTAM; Ram ; et al.	2019-01-24
An Improved Process For The Preparation Of Macitentan App 20180370954 - Jamjanam; Srivardhana Rao ; et al.	2018-12-27
Co-crystals Of Sglt2 Inhibitors, Process For Their Preparation And Pharmaceutical Compositions Thereof App 20180362514 - CHIVUKULA; KAMESWAR Rao ; et al.	2018-12-20
Process For The Preparation And Particle Size Reduction Of Pirfenidone App 20180334434 - BOLLU; Ravindra Badu ; et al.	2018-11-22
Process for the preparation of Enzalutamide Grant 10,131,636 - Chivukula , et al. November 20, 2	2018-11-20
Processes For The Preparation Of Ivacaftor App 20180244622 - Thatipally; Suresh ; et al.	2018-08-30
Novel Process For The Preparation Of Dolutegravir And Pharmaceutically Acceptable Salts Thereof App 20180155364 - CHAVA; Satyanarayana ; et al.	2018-06-07
Polymorphs of Ivacaftor, process for its preparation and pharmaceutical composition thereof Grant 9,957,234 - Thaimattam , et al. May 1, 2	2018-05-01
Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof Grant 9,856,271 - Chava , et al. January 2, 2	2018-01-02
Novel Polymorphs Of Ivacaftor, Process For Its Preparation And Pharmaceutical Composition Thereof App 20170334860 - THAIMATTAM; Ram ; et al.	2017-11-23
An Improved Process For The Preparation Of Enzalutamide App 20170313662 - Chivukula; Kameswar Rao ; et al.	2017-11-02
Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof Grant 9,650,346 - Indukuri , et al. May 16, 2	2017-05-16
Process for the preparation of Ivacaftor and its intermediates Grant 9,573,902 - Thatipally , et al. February 21, 2	2017-02-21
Novel Process For The Preparation Of Dolutegravir And Pharmaceutically Acceptable Salts Thereof App 20160333026 - CHAVA; Satyanarayana ; et al.	2016-11-17
Process for preparation of montelukast sodium Grant 9,487,487 - Simhadri , et al. November 8, 2	2016-11-08
An Improved Process For The Preparation Of Pazopanib Or A Pharmaceutically Acceptable Salt Thereof App 20160280689 - CHAVA; Satyanarayana ; et al.	2016-09-29
Salts of sitagliptin, process from the preparation and pharmaceutical composition therefore Grant 9,388,113 - Indukuri , et al. July 12, 2	2016-07-12
Salts of Sitagliptin, Process from the Preparation and Pharmaceutical Composition Therefore App 20160122274 - Indukuri; Venkata Sunil Kumar ; et al.	2016-05-05
Process For The Preparation Of Ivacaftor And Its Intermediates App 20160016909 - THATIPALLY; Suresh ; et al.	2016-01-21
Salts of sitagliptin, process for the preparation and pharmaceutical composition therefore Grant 9,181,256 - Indukuri , et al. November 10, 2	2015-11-10
Process For Preparation Of Montelukast Sodium App 20150299127 - INDUKURI; Venkata ; et al.	2015-10-22
Efficient process to induce enantioselectivity in procarbonyl compounds Grant 9,073,817 - Bollu , et al. July 7, 2	2015-07-07
Process for the preparation of tenofovir Grant 9,056,882 - Indukuri , et al. June 16, 2	2015-06-16
Process for the preparation of polyhydroxystilbene compounds by deprotection of the corresponding ethers Grant 8,987,525 - Dorwal , et al. March 24, 2	2015-03-24
Process For The Preparation Of Polyhydroxystilbene Compounds By Deprotection Of The Corresponding Ethers App 20150031921 - Dorwal; Harish Niranjanlal ; et al.	2015-01-29
Process For The Preparation Of Tenofovir App 20140303368 - Indukuri; Venkata Sunil Kumar ; et al.	2014-10-09
Process for the preparation of Tenofovir Grant 8,791,259 - Chava , et al. July 29, 2	2014-07-29
Solid Forms Of Antiretroviral Compounds, Process For The Preparation And Their Pharmaceutical Composition Thereof App 20140094475 - Indukuri; Venkata S. ; et al.	2014-04-03
Novel Salts Of Sitagliptin, Process For The Preparation And Pharmaceutical Composition Thereof App 20140073791 - Indukuri; Venkata Sunil Kumar ; et al.	2014-03-13
Process For The Preparation Of Tenofovir App 20130165413 - CHAVA; Satyanarayana ; et al.	2013-06-27
Process for preparing Montelukast and salts thereof Grant 8,367,834 - Indukuri , et al. February 5, 2	2013-02-05
Efficient Process To Induce Enantioselectivity In Procarbonyl Compounds App 20120264933 - BOLLU; Ravindra Babu ; et al.	2012-10-18
Process For Preparing Montelukast And Salts Thereof App 20120232276 - INDUKURI; Venkata Sunil Kumar ; et al.	2012-09-13
Process for preparing montelukast and salts thereof Grant 8,207,343 - Indukuri , et al. June 26, 2	2012-06-26
Process for the preparation of almotriptan Grant 7,943,784 - Chava , et al. May 17, 2	2011-05-17
Improved Process For Preparing Montelukast And Salts Thereof App 20110112300 - Indukuri; Venkata Sunil Kumar ; et al.	2011-05-12
Process for the preparation of Telmisartan Grant 7,884,214 - Chava , et al. February 8, 2	2011-02-08
Process for the Preparation of Montelukast and its Salts App 20090143590 - Chava; Satyanarayana ; et al.	2009-06-04
Process for the Preparation of Telmisartan App 20090023932 - Chava; Satyanarayana ; et al.	2009-01-22
Process for the Preparation of Almotriptan App 20080234495 - Chava; Satyanarayana ; et al.	2008-09-25
Process for the production of citalopram Grant 7,365,216 - Abbineni , et al. April 29, 2	2008-04-29
Process for the preparation of gabapentin form-II App 20060235079 - Chava; Satyanarayana ; et al.	2006-10-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.